Comparative Effects Between Direct Oral Anticoagulants for Acute Venous Thromboembolism: Indirect Comparison From Randomized Controlled Trials
Background: There is no direct comparison from clinical trials amongst the direct oral anticoagulants (DOACs) in patients with acute venous thromboembolism (VTE), leaving an evidence gap in decision-making regarding the choice of a DOAC.Methods: We performed a systematic review for an indirect compa...
Main Authors: | Guowei Li, Jie Zeng, Junguo Zhang, Lehana Thabane |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2020.00280/full |
Similar Items
-
Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol
by: Faizan Khan, et al.
Published: (2019-10-01) -
Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity
by: Alexander Cohen, et al.
Published: (2021-01-01) -
Oral anticoagulants: Optimizing venous thromboembolism management
by: Fahad A S. Aleidan
Published: (2019-01-01) -
Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous Thromboembolism
by: Juan J. López-Núñez, et al.
Published: (2019-01-01) -
Direct oral anticoagulants in cancer-associated venous thromboembolism
by: Kirill Lobastov, et al.
Published: (2020-01-01)